Linking intangible resources and competition
Article Abstract:
When a company is able to compete successfully within a market the effectiveness of the intangible resources within the firm will have had an important role. Therefore firms should work towards using their intangible resources, such as relationships and competencies, to help them succeed in the most suitable market. Within industry there are several ways of competing; operational, contractural and entrepreneurial. Each type of competition requires different relationships and competencies. Firms trying to compete in markets not supported by the relevant resources may fail.
Publication Name: European Management Journal
Subject: Business, international
ISSN: 0263-2373
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Separating research from development: evidence from the pharmaceutical industry
Article Abstract:
Some companies are now beginning to view research and development as separate functions, going against the traditional practice of a single approach to research and development. This is particularly clear in the pharmaceutical industry, where research and development play a very strong role. Pharmaceutical companies which have separated research and development have selected different points at which to split up these operations, and it has proved hard to define exactly the dividing line between discovery and development.
Publication Name: European Management Journal
Subject: Business, international
ISSN: 0263-2373
Year: 1996
User Contributions:
Comment about this article or add new information about this topic:
Adaption to change: vertical and horizontal integration in the drug industry
Article Abstract:
Biotechnology companies became a threat to the drug industry during the 1990s. High drug prices were criticized by governments which were keen to reduce health care costs, and generic drugs became more popular. The drug industry responded to these issues by embracing horizontal and vertical integration. Vertical acquisitions allows drug companies to gain control of the entire supply chain, while horizontal acquisitions ensure that the drug companies can get involved in political debate on issues such as health reform in order to maintain their profitability levels.
Publication Name: European Management Journal
Subject: Business, international
ISSN: 0263-2373
Year: 1997
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Expert commentaries. The urge to merge in the pharmaceutical industry
- Abstracts: Shipping to and across Central America. Africa: the going is tough. The advantages of the Caribbean
- Abstracts: Lucent revenue rises 33% as foreign sales increase. Lucent exceeds profit estimates as sales surge. Lucent warns quarterly profit will fall short
- Abstracts: ABN Amro has new approach to trading. ABN Amro causes stir in Italy. ABN Amro may shuffle U.S. business
- Abstracts: Made in Manchester. The Wright spirit. Wild at heart